| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former Officer and Director | CFO
1 company
Steven W Weldon last filed a Form 4 in December 2020, as Former Officer and Director at GTBP. Steven W Weldon's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 3,720,000 shares of GTBP. The GTBP filings lean toward selling, a net 3,049,708 shares.
Steven W Weldon has 6 Form 4 filings on record from September 2017 to December 2020, all as Former Officer and Director at GT Biopharma (GTBP), 2017–2020.
The 19 reported transactions were 17 open-market sales and 2 stock awards.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $239K.
The largest open-market sale was 396,300 shares of GTBP at an average $0.29 on December 15, 2020, about $113K.
Shares as reported in the last Form 4 for each company; the most recent is from December 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2020 | GTBP Gt Biopharma, Inc. | Former Officer and Director | Sell | 183,700 | $0.34 | $62,836.68 | -4.7% | |
| Dec 18, 2020 | GTBP Gt Biopharma, Inc. | Former Officer and Director | Sell | 200,000 | $0.30 | $60,500.00 | -4.9% | |
| Dec 15, 2020 | GTBP Gt Biopharma, Inc. | Former Officer and Director | Sell | 396,300 | $0.29 | $113,427.00 | -8.8% | |
| May 13, 2020 | GTBP Gt Biopharma, Inc. | CFO | Sell | 2,269,708 | $0.00 | $2,269.71 | -33.5% |